Clinical Trial Update: DEFINITIVE AR Two Year Follow-up Extension Study

View source ↗

Summary

Clinical trial update noting completion of the DEFINITIVE AR two-year follow-up extension study sponsored by Medtronic Endovascular for Peripheral Arterial Dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• DEFINITIVE AR

Snippet

Sponsor: Medtronic Endovascular | Conditions: Peripheral Arterial Disease | Status: COMPLETED